Reason for request
Inclusion
Clinical Benefit
| Substantial |
Substantial actual benefit |
Clinical Added Value
| no clinical added value |
EYLEA 40 mg/ml, solution for injection in a prefilled syringe and solution for injection in a vial, does not provide an improvement in actual benefit (IAB V) compared with LUCENTIS 10 mg/ml, solution for injection. |
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
ELT8Su8A4pXebGRN
